Glaser Weil Represents p-value Group in Sale to Publicis Health

Glaser Weil is proud to announce its role as mergers and acquisition counsel to P Value Communications LLC, and its affiliated entities (the “p-value Group of Companies”), in its sale to Publicis Health, the world’s most connected and data-powered health communications network and part of Publicis Groupe, a publicly traded French multinational advertising and public relations company.

Founded in 2004 and headquartered in Cedar Knolls, New Jersey, p-value Group is a premier full-service medical communications organization serving top-tier life sciences clients. Known for its scientific rigor, deep therapeutic expertise and a team of advanced-degree professionals, p-value supports clients across the full product lifecycle—from early-stage development to commercialization. The group includes P Value Communications LLC and Scient Healthcare Communications LLC.

This strategic acquisition underscores the growing importance of specialized healthcare communications in the global marketplace. It will position Publicis Health to accelerate innovation in medical communications by integrating data, technology, creative and scientific integrity to drive outcomes-focused health results.

p-value Group will continue to be led by its Founder and CEO, Linda Corvari, PharmD, and will operate within Publicis Health alongside Langland Medical and Razorfish Health. The transaction is expected to close by the end of August 2025, subject to customary regulatory approvals.

The Glaser Weil deal team was co-led by George Wall and Matthew Jann, with support from Jeff Soza and Charles Martin.

View the press release to learn more.